Cyclosporin A mediated immunosuppression in vitro: effect on high affinity interleukin‐2 receptor expression and ‐turnover
- 1 January 1989
- journal article
- research article
- Published by Wiley in Tissue Antigens
- Vol. 33 (1) , 4-14
- https://doi.org/10.1111/j.1399-0039.1989.tb01671.x
Abstract
The effect of in vitro administration of Cyclosporin A (CsA) during mitogen, antigen and alloantigen activation of human T‐lymphocytes on high affinity interleukin‐2 (IL‐2) receptor expression and ‐turnover and IL‐2 production was investigated. The presence of CsA reduced 3H‐thymidine incorporation and binding of radiolabeled human recombinant (ala125) IL‐2 to high‐affinity receptors in a dose‐dependent fashion, although a pronounced inter‐ and intra‐individual variation in sensitivity to CsA mediated immunosuppression was observed. Maximum inhibition was obtained when antigen and CsA were added to culture medium simultaneously. Preincubation with CsA did not influence the response. Although the number of IL‐2 receptors was reduced, the turnover of the remaining high affinity IL‐2 receptors on CsA treated cells was unaffected. Thus, binding, internalization and degradation were qualitatively unaltered by CsA administration. Finally, T cell activation in the presence of CsA reduced radioimmuno detectable IL‐2 in cell culture supematants to about 20%. CsA, added during antigen activation, reduced the number of Tac antigen presenting cells, but anti‐Tac was unable to detect variations in the expression of high affinity IL‐2 receptors. The present data indicate that CsA mediates immunosuppression by affecting early events during T‐cell activation, and that variations in high affinity IL‐2 receptor expression and IL‐2 production are secondary to this affection.This publication has 27 references indexed in Scilit:
- Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-Receptors: Interrelationship between 33B3.1, Anti-Tac, and IL2 binding sitesHuman Immunology, 1987
- Binding, uptake and degradation of human recombinant interleukin‐2 (125 ala) in activated human T‐ and B‐lymphocytes and in monocyte‐macrophagesTissue Antigens, 1987
- COMPARISON OF THE IMMUNOSUPPRESSIVE EFFECTS OF CYCLOSPORINE, LIPID-SOLUBLE ANESTHETICS, AND CALMODULIN ANTAGONISTSTransplantation, 1986
- Inhibition of in Vitro Alloreactivity by Cyclosporin A: Evidence for an Inter‐Individual Variation in SensitivityScandinavian Journal of Immunology, 1986
- Only high-affinity receptors for interleukin 2 mediate internalization of ligand.Proceedings of the National Academy of Sciences, 1986
- CORRELATION OF HLA MATCHING WITH KIDNEY GRAFT SURVIVAL IN PATIENTS WITH OR WITHOUT CYCLOSPORINE TREATMENTTransplantation, 1985
- Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.The Journal of Immunology, 1983
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Crystal and Molecular Structure of an Iodo‐derivative of the Cyclic Undecapeptide Cyclosporin AHelvetica Chimica Acta, 1976